Bal Pharma Ltd.

₹81.09

-3.5 (-4.1%)

BALPHARMA Share Price

Pharmaceuticals & Biotechnology

As on October 23, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 129.91 Cr

P/E Ratio20.55

Dividend Yield0.15 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	88.08	Bearish
10-DMA	92.67	Bearish
20-DMA	98.73	Bearish
50-DMA	95.55	Bearish
100-DMA	90.57	Bearish
200-DMA	82.37	Bearish

Historical Performance

1 Year

-1.6%

3 Years

-5.7%

5 Years

-17.5%

10 Years

-31.6%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	3,117	3,031	3,392	3,042	2,812
Total Expenditure	2,796	2,733	3,083	2,790	2,572
Other Income	19	22	28	9	52
Operating Profit	340	320	338	262	291
Interest	170	171	147	123	109
Depreciation	111	98	101	91	90
Profit Before Tax	59	51	90	47	92
Consolidated Net Profit	63	72	74	26	56
Adjusted EPS	4	5	5	2	4

Compounded Sales Growth

10 Years:9.5

5 Years:4.5

3 Years:0.5

TTM:0.6

Compounded Profit Growth

10 Years:34.9

5 Years:5.8

3 Years:19.6

TTM:-2.7

Stock Price CAGR

10 Years:-3.7

5 Years:-3.8

3 Years:-1.9

TTM:-3.2

Return on Equity

10 Years:1.2

5 Years:3.8

3 Years:4.7

last year:3.9

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	159	159	158	157	148
Total Reserves	663	615	562	481	429
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	433	384	448	380	364
Other Current Liabilities	464	293	267	311	242
Short Term Borrowings	1,130	1,073	958	927	707
Total Liabilities	3,747	3,353	3,198	3,110	2,605
Capital Work in Progress	74	28	5	---	16
Long Term Loans & Advances	57	64	52	46	50
Currents Investments	21	25	68	---	---
Short Term Loans and Advances	285	229	221	248	170
Total Current Assets	2,622	2,349	2,342	2,282	1,846
Total Assets	3,747	3,353	3,198	3,110	2,605
Adjusted Book Value	52	49	46	41	39

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a moderate PE of 20.55, suggesting fair valuation relative to earnings.
Over the last three years, the stock delivered a weak 3-year price CAGR of -2.0%, indicating poor shareholder returns.
The stock carries a beta of 0.8, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹340 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹3117 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 968123.2

No. of Shares: 11939 (Approx)

Performance:-3.2%

-31876.8

NIFTY Performance: -12.4%

1 day Top Gainers